IBJNews

Lilly woes take notch out of debt rating

Back to TopCommentsE-mailPrintBookmark and Share

Even with debt levels at Eli Lilly and Co. at paltry lows, the bad news finally forced Standard & Poor’s to lower its rating on the company’s senior unsecured debt. But the New York-based agency said it believes the Indianapolis-based drugmaker will eventually break its string of bad luck on developing products.

S&P dropped its rating on Lilly debt to AA- from AA on Aug. 19, citing the company’s string of late-stage clinical-trial failures, a couple of court losses over patents on existing drugs, the disappointing sales of its newest product, Effient, and, of course, looming patent expirations on its two top-selling drugs.

"The rating action considers the disappointments and delays for both new and existing products experienced by this top-tier drug company, which we believe weaken its ability to offset the lost revenues for products facing generic competition over the next three years," credit analyst David Lugg said in a statement.

Lugg noted that Lilly’s debt represents just 60 percent of the company’s cash flow, as measured by earnings before interest, taxes, depreciation and amortization. That’s well below S&P’s desired maximum of 150 percent.

Lugg and his colleagues retained their rating on Lilly’s bonds and their stable outlook for the company, saying that they hold the "expectation that Lilly will continue to pursue conservative financial policies while improving its new-product-development success rate.”

S&P’s downgrade decision was made before Lilly received a federal committee's recommendation to market its drug Cymbalta to treat chronic pain. The antidepressant is already Lilly’s No. 2 drug, behind the antipsychotic Zyprexa. Some analysts expect the new use to add $500 million to Cymbalta’s more than $3 billion in annual sales.

On Friday, Lilly won a delay of a court decision that invalidated its U.S. patent on Strattera, an attention-deficit hyperactivity disorder medicine with about $600 million in worldwide sales. Lilly is moving to appeal that decision.

Lilly also said last week it would push ahead with its second experimental Alzheimer’s drug after its first candidate actually worsened patients' condition during a large, late-stage clinical trial.

ADVERTISEMENT

  • All the best
    Lilly has 40,000 of the best minds in the world working for them.
    China could be consumer for Lilly's cash cow Zyprexa which has been reproached in the States for adverse litigation.
    All the best for Eli Lilly and resolution of Zyprexa claims
    -
    Daniel Haszard

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
  1. On my rental property, before tax caps, I was paying $2,000/yr in property taxes. After the tax caps I'm paying $4,000/yr. How exactly am I "benefiting the most"?

  2. Nick, I too tried that new Walmart NM on Michigan a couple of weeks ago. I had the same feeling, it had good prices, but something was just off about it. I can't put my finger on what it is, but it just didn't feel right. On the plus side, it was easy to get in and out of and much less busy than a typical Walmart.

  3. @Young Hoosier - you might want to check out the Paris skyline again....it's decidedly taller than 7-8 stories http://all-that-is-interesting.com/paris-skyline-photo

  4. Are you in need of Loan or financial help?, you need a loan for your business or to solve other monetary issues. James Lewis Loan Company started offering loans with a very low interest rate of 3% for a minimum of 15 years, Interested applicants should submit their request via email (jameslewisloan@gmail.com) for immediate processing with the information listed below: Names in full:................ Address:...................... Gender:.................... Email:........................ Phone Number:....... Amount Required:... Loan Duration:....... Country:................. Occupation:.................. ================================== In acknowledgment to these details, I will send you a well calculated Terms and Conditions for the amount you require. Warm Regards, Mr James Lewis

  5. So the GOP legislature passed a bill that gave big breaks to business at the expense of Indiana families. Color us not surprised.

ADVERTISEMENT